- Guideline Update: Treatment of Chronic HCV with DAAs (12/9/19)
- Three New Tables Added to the Drug-Drug Interactions Resource (11/25/19)
- Guideline Update: New Monitoring Intervals for CD4 Cell Count (11/22/19)
- New Guideline: PrEP to Prevent HIV and Promote Sexual Health (10/14/19)
- New Guideline: Laboratory Monitoring for Adverse Effects of ART (9/10/19)
- New Guideline: Treatment of Opioid Use Disorder (8/29/19)
- New Guideline: Harm Reduction Approach to Treatment of All Substance Use Disorders (8/29/19)
- Pocket Guide to Treatment of Opioid Use Disorder and Harm Reduction (9/3/19)
- U=U Guidance for Implementation in Clinical Settings (8/21/19)
- Pocket Guide to U=U Guidance for Implementation in Clinical Settings (8/27/19)
Skip to content
NEW YORK STATE DEPARTMENT OF HEALTH AIDS INSTITUTE See Our Statement on Inclusive Care
